Morgan Stanley Says China’s Reusable Rocket Progress Poses Long-Term Challenge to SpaceX 
Fast Retailing Raises Full-Year Forecast After Uniqlo Owner Beats Q3 Profit Estimates 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Goldman AM Sees Strong Buyout Opportunities in Japan, South Korea and Australia 
Oppenheimer Sees CNH Industrial as Top 2026 Agriculture Stock Pick on Dealer Consolidation Strategy 
Morgan Stanley Names Marks & Spencer Top European Retail Pick, Sees Strong Upside 
Kitron Q2 Revenue Beats Estimates as Defense Demand Lifts Growth 
Nvidia Invests $500M in Firmus Technologies Ahead of Planned ASX IPO 
BHP Faces Port Hedland Strike Threat as Iron Ore Export Risks Grow 
OpenAI Executive Fidji Simo to Step Down Amid Health Challenges Ahead of IPO 
Bernstein Names IAG, Ryanair as Top European Airline Stocks Ahead of Earnings 
Bain Capital Exits Kioxia After AI-Fueled Valuation Surge 
SK Hynix Prices Record U.S. ADR Offering at $149 After $200 Billion Investor Demand 
Apple Sues OpenAI, Former Employees Over Alleged Trade Secret Theft 
Levi Strauss Raises 2026 Outlook After Q2 Earnings Beat, Shares Drop Despite Strong Results 
Mastercard Explores Sale of Majority Stake in UK Payments Firm Vocalink: Report 
SAN FRANCISCO, April 23, 2018 -- A newly published market research report from Neurotech Reports predicts that the global market for neurotechnology products will be $8.4 billion in 2018 and grow to $13.3 billion by 2022, a 12-percent compound annual growth rate. The report, titled The Market for Neurotechnology: 2018-2022, tracks U.S. and worldwide sales of neurotechnology products in four major categories: neuromodulation, neuroprosthetics, neurorehabilitation, and neurosensing. Neurotech Reports has been tracking the growth of the neurotechnology market since 2001, longer than any other research firm in this space.
The largest segment of the global neurotechnology market is neuromodulation systems, which will grow from $4.7 billion in 2018 to $7.6 billion in 2022. Worldwide sales of neuroprosthetics systems will grow from $2.1 billion in 2018 to $3.3 billion in 2022, according to the report.
For the first time, Neurotech Reports projects that Medtronic is no longer the market leader in sales of spinal cord stimulation systems. Abbott, which acquired St. Jude Medical last year, will have the largest share of the crowded SCS market in 2018, with Boston Scientific, Medtronic, and Nevro close behind. Medtronic will retain its leadership in the deep brain stimulation market, but steadily lose market share to new players by 2020.
“The neurotechnology industry is currently undergoing dramatic changes in competitive landscape, more so than any other time in the 18 years that we have been covering this market,” said James Cavuoto, editor and publisher of Neurotech Reports. “With several new technologies and new applications on the horizon, we expect to see continued changes in the years ahead.”
The Market for Neurotechnology: 2018-2022 is available from Neurotech Reports for $2495 (single reader), $3295 (2-5 readers), or $4595 (6-10 readers). The report is available to premium subscribers of Neurotech Business Report at no additional charge. To order, visit http://www.neurotechreports.com/pages/reportsumm.html or contact Neurotech Reports at 415 546 1259.
MEDIA ONLY CONTACT:
James Cavuoto
Neurotech Reports
+1-415-546-1259
[email protected]
